Rani Therapeutics Holdings, Inc. Research And Development Expense

• Rani Therapeutics Holdings, Inc. showed a decrease of -24.3% in Research And Development Expense from 2024 to 2025.
• This data is from Rani Therapeutics Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Rani Therapeutics Holdings, Inc.'s Research And Development Expense has grown by 67.8%.
• Historical annual values: Fiscal year 2025: $20.21 million | Fiscal year 2024: $26.68 million | Fiscal year 2023: $39.62 million | Fiscal year 2022: $36.61 million | Fiscal year 2021: $26.48 million | Fiscal year 2020: $12.04 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026